Trial Outcomes & Findings for You and Me COVID Free (NCT NCT05212883)

NCT ID: NCT05212883

Last Updated: 2023-06-06

Results Overview

Those that used a test from a kit were asked to provide the reason why they were doing a test. The possible answers are: "I wanted to be sure I/my child did not have COVID-19 before being around others", "I/my child had COVID-19 like symptoms", "I/my child was in close contact with someone who might have COVID-19", "I/my child was in close contact with someone who tested positive for COVID-19", "Someone in my household might have COVID-19", "Someone in my household tested positive for COVID-19", "Other"

Recruitment status

COMPLETED

Target enrollment

2778 participants

Primary outcome timeframe

Baseline

Results posted on

2023-06-06

Participant Flow

The project team utilized a robust communications campaign and mobilized community partners to assist with outreach and to organize COVID-19 (SARs-CoV-2) antigen testing kit distribution events. Community members received tests via in person at local distribution centers and events.

Participant milestones

Participant milestones
Measure
Behavioral Questionnaires
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Overall Study
STARTED
2778
Overall Study
COMPLETED
2653
Overall Study
NOT COMPLETED
125

Reasons for withdrawal

Reasons for withdrawal
Measure
Behavioral Questionnaires
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Overall Study
Invalid test result
125

Baseline Characteristics

You and Me COVID Free

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Behavioral Questionnaires
n=1001 Participants
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Age, Continuous
39 years
n=5 Participants
Sex/Gender, Customized
Female
687 Participants
n=5 Participants
Sex/Gender, Customized
Male
280 Participants
n=5 Participants
Sex/Gender, Customized
Unknown or Not Reported
34 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
529 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
434 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
38 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
35 Participants
n=5 Participants
Race (NIH/OMB)
Asian
74 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
5 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
39 Participants
n=5 Participants
Race (NIH/OMB)
White
546 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
36 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
266 Participants
n=5 Participants
Region of Enrollment
United States
1001 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline

Those that used a test from a kit were asked to provide the reason why they were doing a test. The possible answers are: "I wanted to be sure I/my child did not have COVID-19 before being around others", "I/my child had COVID-19 like symptoms", "I/my child was in close contact with someone who might have COVID-19", "I/my child was in close contact with someone who tested positive for COVID-19", "Someone in my household might have COVID-19", "Someone in my household tested positive for COVID-19", "Other"

Outcome measures

Outcome measures
Measure
Behavioral Questionnaires
n=2778 Participants
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Main Reason for Testing for COVID-19
I wanted to be sure I/my child did not have COVID-19 before being around others
1632 Participants
Main Reason for Testing for COVID-19
I/my child was in close contact with someone who might have COVID-19
238 Participants
Main Reason for Testing for COVID-19
I/my child was in close contact with someone who tested positive for COVID-19
343 Participants
Main Reason for Testing for COVID-19
I/my child had COVID-19 like symptoms
493 Participants
Main Reason for Testing for COVID-19
Someone in my household might have COVID-19
118 Participants
Main Reason for Testing for COVID-19
Someone in my household tested positive for COVID-19
152 Participants
Main Reason for Testing for COVID-19
Other
209 Participants

PRIMARY outcome

Timeframe: Baseline

Outcome measures

Outcome measures
Measure
Behavioral Questionnaires
n=2778 Participants
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Number of Positive COVID-19 Test Results
269 Participants

PRIMARY outcome

Timeframe: Baseline

Population: Participants who completed the baseline survey.

Outcome measures

Outcome measures
Measure
Behavioral Questionnaires
n=1001 Participants
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Number of Participants Who Responded That They Have Received a COVID Vaccine
850 Participants

SECONDARY outcome

Timeframe: Baseline

Population: Participants who completed the baseline survey.

Outcome measures

Outcome measures
Measure
Behavioral Questionnaires
n=1001 Participants
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Number of Participants Who Indicated That They Have Access to Necessary Personal Protective Equipment in Work Place
475 Participants

SECONDARY outcome

Timeframe: Baseline

Population: Participants who completed the baseline survey and indicated having tested for COVID.

Outcome measures

Outcome measures
Measure
Behavioral Questionnaires
n=821 Participants
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Number of Participants Who Indicated They Have Tested Positive for COVID in Their Lifetime
237 Participants

SECONDARY outcome

Timeframe: Baseline

Population: Participants who completed the baseline survey.

Outcome measures

Outcome measures
Measure
Behavioral Questionnaires
n=1001 Participants
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Number of Participants Who Report Knowing Where to Get COVID-19 Tests in the Community
757 Participants

SECONDARY outcome

Timeframe: Baseline

Population: Participants who completed the baseline survey.

Outcome measures

Outcome measures
Measure
Behavioral Questionnaires
n=1001 Participants
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Number of Participants Who Report COVID Symptoms During Previous Week
627 Participants

SECONDARY outcome

Timeframe: Baseline

Population: Participants with front door survey entries that indicated the responder had not received a COVID-19 vaccine.

Number of participants with front door survey entries indicating various levels of the likelihood the responder will get vaccinated in the future. Available options: "Very likely", "Somewhat likely", "Not very likely", "Not at all likely", and "Prefer not to answer".

Outcome measures

Outcome measures
Measure
Behavioral Questionnaires
n=489 Participants
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Likelihood of Future COVID-19 Vaccination
Very likely
119 Participants
Likelihood of Future COVID-19 Vaccination
Somewhat likely
140 Participants
Likelihood of Future COVID-19 Vaccination
Not very likely
59 Participants
Likelihood of Future COVID-19 Vaccination
Not at all likely
92 Participants
Likelihood of Future COVID-19 Vaccination
Prefer not to answer/missing
79 Participants

SECONDARY outcome

Timeframe: Baseline

Population: Participants who indicated they have not received a COVID-19 vaccine on the baseline survey. More than one answer can be selected by an individual participant.

Number of participants indicating various reasons for why they have not received a COVID-19 vaccine on the baseline survey. Available options: "I'm allergic to vaccines", "I don't like needles", "I'm not concerned about getting really sick from COVID-19", "I'm concerned about side effects from the vaccines", "I don't think vaccines work very well", "I don't trust that the vaccines will be safe", "I don't believe the COVID-19 pandemic is as bad as some people say it is", "I don't want to pay for it", and "I don't know enough about how well a COVID-19 vaccine works".

Outcome measures

Outcome measures
Measure
Behavioral Questionnaires
n=121 Participants
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Reasons for Not Getting a COVID-19 Vaccine
I don't like needles
22 Participants
Reasons for Not Getting a COVID-19 Vaccine
I'm not concerned about getting really sick from COVID-19
3 Participants
Reasons for Not Getting a COVID-19 Vaccine
I'm concerned about side effects from the vaccines
47 Participants
Reasons for Not Getting a COVID-19 Vaccine
I don't trust that the vaccines will be safe
34 Participants
Reasons for Not Getting a COVID-19 Vaccine
I don't believe the COVID-19 pandemic is as bad as some people say it is
4 Participants
Reasons for Not Getting a COVID-19 Vaccine
I don't want to pay for it
3 Participants
Reasons for Not Getting a COVID-19 Vaccine
I don't know enough about how well a COVID-19 vaccine works
16 Participants
Reasons for Not Getting a COVID-19 Vaccine
I'm allergic to vaccines
5 Participants
Reasons for Not Getting a COVID-19 Vaccine
I don't think vaccines work very well
7 Participants
Reasons for Not Getting a COVID-19 Vaccine
Other
15 Participants

SECONDARY outcome

Timeframe: Baseline

Population: Participants who indicated they have received a COVID-19 vaccine on the baseline survey. More than one answer can be selected by an individual participant.

Number of participants indicating various reasons for why they have received a COVID-19 vaccine on the baseline survey. Available options: "I want to keep my family safe", "I want to keep my community safe", "I want to keep myself safe", "I have a chronic health problem, like asthma or diabetes", "My doctor told me to get a COVID-19 vaccine", "I don't want to get really sick from COVID-19", "I want to feel safe around other people", "I believe life won't go back to normal until most people get a COVID-19 vaccine", "Required by my school or workplace", and "Required for travel".

Outcome measures

Outcome measures
Measure
Behavioral Questionnaires
n=850 Participants
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Reasons for Getting a COVID-19 Vaccine
I want to keep my family safe
712 Participants
Reasons for Getting a COVID-19 Vaccine
I want to feel safe around other people
404 Participants
Reasons for Getting a COVID-19 Vaccine
I want to keep my community safe
477 Participants
Reasons for Getting a COVID-19 Vaccine
I want to keep myself safe
557 Participants
Reasons for Getting a COVID-19 Vaccine
I have a chronic health problem, like asthma or diabetes
135 Participants
Reasons for Getting a COVID-19 Vaccine
My doctor told me to get a COVID-19 vaccine
86 Participants
Reasons for Getting a COVID-19 Vaccine
I don't want to get really sick from COVID-19
378 Participants
Reasons for Getting a COVID-19 Vaccine
I believe life won't go back to normal until most people get a COVID-19 vaccine
313 Participants
Reasons for Getting a COVID-19 Vaccine
Required by my school or workplace
169 Participants
Reasons for Getting a COVID-19 Vaccine
Required for travel
126 Participants
Reasons for Getting a COVID-19 Vaccine
Other
24 Participants

SECONDARY outcome

Timeframe: Baseline

Number of front door survey entries indicating various ways in which participants would find it easy to get free COVID-19 oral medications. Available options: "An urgent care center". "A doctor's or other health professional's office", "A mobile health unit", "A drug store / pharmacy", "A grocery store", "A community center", "A place of worship", "A community park", "A neighborhood school", or "other". More than one answer can be selected by an individual participant.

Outcome measures

Outcome measures
Measure
Behavioral Questionnaires
n=2778 Participants
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Perspective on Easiest Way to Obtain Free Oral COVID-19 Medications
An urgent care center
503 Participants
Perspective on Easiest Way to Obtain Free Oral COVID-19 Medications
A doctor's or other health professional's office
526 Participants
Perspective on Easiest Way to Obtain Free Oral COVID-19 Medications
A mobile health unit
189 Participants
Perspective on Easiest Way to Obtain Free Oral COVID-19 Medications
A drug store / pharmacy
1225 Participants
Perspective on Easiest Way to Obtain Free Oral COVID-19 Medications
A grocery store
209 Participants
Perspective on Easiest Way to Obtain Free Oral COVID-19 Medications
A community center
87 Participants
Perspective on Easiest Way to Obtain Free Oral COVID-19 Medications
A place of worship
38 Participants
Perspective on Easiest Way to Obtain Free Oral COVID-19 Medications
A community park
50 Participants
Perspective on Easiest Way to Obtain Free Oral COVID-19 Medications
A neighborhood school
116 Participants
Perspective on Easiest Way to Obtain Free Oral COVID-19 Medications
Other
25 Participants

SECONDARY outcome

Timeframe: Baseline

Population: Participants who indicated that they have tested for COVID-19.

Number of participants indicating the method used to test for COVID-19 on the baseline survey. Available options: "Nasal swab", "Throat swab", "Blood sample", and "Saliva".

Outcome measures

Outcome measures
Measure
Behavioral Questionnaires
n=821 Participants
Questionnaires will collect data on demographic characteristics, medical history and health status, COVID testing and symptoms, social interactions, knowledge of prevention strategies, infection risk, and attitudes towards vaccines.
Method Used to Test for COVID-19
Saliva
17 Participants
Method Used to Test for COVID-19
Missing
2 Participants
Method Used to Test for COVID-19
Nasal swab
783 Participants
Method Used to Test for COVID-19
Throat swab
15 Participants
Method Used to Test for COVID-19
Blood sample
4 Participants

Adverse Events

Behavioral Questionnaires

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Saira Siddiqui, M.P.H.

Duke University

Phone: 919-688-8464

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place